Characterization of tumor-induced platelet aggregation

The role of immunorelated GPIb and GPIIb IIIa expression by MCF-7 breast cancer cells

Leslie Oleksowicz, Zbigniew Mrowiec, Edward L. Schwartz, Manoochehr Khorshidi, Janice P. Dutcher, Elena Puszkin

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Tumor cell induced platelet aggregation is thought to be an early step in the metastatic process. Here we show that platelet aggregation induced by MCF-7 cells is mediated, in part, through an ADP-dependent mechanism based on inhibition of aggregation by pretreatment of the tumor cells with apyrase and the identification of ADP in tumor cell-free supernatants by HPLC. By applying immunocytochemical and flow cytometric techniques, we demonstrate that platelet immunorelated glycoproteins, GPIb, GPIIb IIIa, GPIb IX, and the integrin αv subunit are expressed on the surface of MCF-7 cells. The expression of an immunorelated GPIb was further confirmed by immunoblot and autoradiography of 125I-labelled MCF-7 cells. MCF-7 cell immunoblot preparations demonstrated one major protein reactive to an anti-GPIbα MoAb under nonreduced conditions with a molecular weight of 200 kD and two major proteins reactive with the anti-GPIbα MoAb under reduced conditions with molecular weights of 92 kD and 38 kD. Platelet aggregation is inhibited by preincubating the MCF-7 cells with antibodies to GPIb and GPIIb IIIa. These findings document expression of adhesive glycoproteins by MCF-7 cancer cells and suggest that these receptors, together with ADP, play a role in tumor induced platelet aggregation.

Original languageEnglish (US)
Pages (from-to)261-274
Number of pages14
JournalThrombosis Research
Volume79
Issue number3
DOIs
StatePublished - Aug 1 1995

Fingerprint

MCF-7 Cells
Platelet Aggregation
Breast Neoplasms
Adenosine Diphosphate
Neoplasms
Molecular Weight
Apyrase
Platelet Membrane Glycoproteins
Autoradiography
Integrins
Adhesives
Glycoproteins
Proteins
High Pressure Liquid Chromatography
Antibodies

Keywords

  • adenosine diphosphate
  • breast carcinoma
  • MCF-7 cultured tumor cells
  • platelet aggregation
  • platelet glycoproteins

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

Characterization of tumor-induced platelet aggregation : The role of immunorelated GPIb and GPIIb IIIa expression by MCF-7 breast cancer cells. / Oleksowicz, Leslie; Mrowiec, Zbigniew; Schwartz, Edward L.; Khorshidi, Manoochehr; Dutcher, Janice P.; Puszkin, Elena.

In: Thrombosis Research, Vol. 79, No. 3, 01.08.1995, p. 261-274.

Research output: Contribution to journalArticle

Oleksowicz, Leslie ; Mrowiec, Zbigniew ; Schwartz, Edward L. ; Khorshidi, Manoochehr ; Dutcher, Janice P. ; Puszkin, Elena. / Characterization of tumor-induced platelet aggregation : The role of immunorelated GPIb and GPIIb IIIa expression by MCF-7 breast cancer cells. In: Thrombosis Research. 1995 ; Vol. 79, No. 3. pp. 261-274.
@article{f027a86be3b5425e9141c429eb7d85d4,
title = "Characterization of tumor-induced platelet aggregation: The role of immunorelated GPIb and GPIIb IIIa expression by MCF-7 breast cancer cells",
abstract = "Tumor cell induced platelet aggregation is thought to be an early step in the metastatic process. Here we show that platelet aggregation induced by MCF-7 cells is mediated, in part, through an ADP-dependent mechanism based on inhibition of aggregation by pretreatment of the tumor cells with apyrase and the identification of ADP in tumor cell-free supernatants by HPLC. By applying immunocytochemical and flow cytometric techniques, we demonstrate that platelet immunorelated glycoproteins, GPIb, GPIIb IIIa, GPIb IX, and the integrin αv subunit are expressed on the surface of MCF-7 cells. The expression of an immunorelated GPIb was further confirmed by immunoblot and autoradiography of 125I-labelled MCF-7 cells. MCF-7 cell immunoblot preparations demonstrated one major protein reactive to an anti-GPIbα MoAb under nonreduced conditions with a molecular weight of 200 kD and two major proteins reactive with the anti-GPIbα MoAb under reduced conditions with molecular weights of 92 kD and 38 kD. Platelet aggregation is inhibited by preincubating the MCF-7 cells with antibodies to GPIb and GPIIb IIIa. These findings document expression of adhesive glycoproteins by MCF-7 cancer cells and suggest that these receptors, together with ADP, play a role in tumor induced platelet aggregation.",
keywords = "adenosine diphosphate, breast carcinoma, MCF-7 cultured tumor cells, platelet aggregation, platelet glycoproteins",
author = "Leslie Oleksowicz and Zbigniew Mrowiec and Schwartz, {Edward L.} and Manoochehr Khorshidi and Dutcher, {Janice P.} and Elena Puszkin",
year = "1995",
month = "8",
day = "1",
doi = "10.1016/0049-3848(95)00113-6",
language = "English (US)",
volume = "79",
pages = "261--274",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Characterization of tumor-induced platelet aggregation

T2 - The role of immunorelated GPIb and GPIIb IIIa expression by MCF-7 breast cancer cells

AU - Oleksowicz, Leslie

AU - Mrowiec, Zbigniew

AU - Schwartz, Edward L.

AU - Khorshidi, Manoochehr

AU - Dutcher, Janice P.

AU - Puszkin, Elena

PY - 1995/8/1

Y1 - 1995/8/1

N2 - Tumor cell induced platelet aggregation is thought to be an early step in the metastatic process. Here we show that platelet aggregation induced by MCF-7 cells is mediated, in part, through an ADP-dependent mechanism based on inhibition of aggregation by pretreatment of the tumor cells with apyrase and the identification of ADP in tumor cell-free supernatants by HPLC. By applying immunocytochemical and flow cytometric techniques, we demonstrate that platelet immunorelated glycoproteins, GPIb, GPIIb IIIa, GPIb IX, and the integrin αv subunit are expressed on the surface of MCF-7 cells. The expression of an immunorelated GPIb was further confirmed by immunoblot and autoradiography of 125I-labelled MCF-7 cells. MCF-7 cell immunoblot preparations demonstrated one major protein reactive to an anti-GPIbα MoAb under nonreduced conditions with a molecular weight of 200 kD and two major proteins reactive with the anti-GPIbα MoAb under reduced conditions with molecular weights of 92 kD and 38 kD. Platelet aggregation is inhibited by preincubating the MCF-7 cells with antibodies to GPIb and GPIIb IIIa. These findings document expression of adhesive glycoproteins by MCF-7 cancer cells and suggest that these receptors, together with ADP, play a role in tumor induced platelet aggregation.

AB - Tumor cell induced platelet aggregation is thought to be an early step in the metastatic process. Here we show that platelet aggregation induced by MCF-7 cells is mediated, in part, through an ADP-dependent mechanism based on inhibition of aggregation by pretreatment of the tumor cells with apyrase and the identification of ADP in tumor cell-free supernatants by HPLC. By applying immunocytochemical and flow cytometric techniques, we demonstrate that platelet immunorelated glycoproteins, GPIb, GPIIb IIIa, GPIb IX, and the integrin αv subunit are expressed on the surface of MCF-7 cells. The expression of an immunorelated GPIb was further confirmed by immunoblot and autoradiography of 125I-labelled MCF-7 cells. MCF-7 cell immunoblot preparations demonstrated one major protein reactive to an anti-GPIbα MoAb under nonreduced conditions with a molecular weight of 200 kD and two major proteins reactive with the anti-GPIbα MoAb under reduced conditions with molecular weights of 92 kD and 38 kD. Platelet aggregation is inhibited by preincubating the MCF-7 cells with antibodies to GPIb and GPIIb IIIa. These findings document expression of adhesive glycoproteins by MCF-7 cancer cells and suggest that these receptors, together with ADP, play a role in tumor induced platelet aggregation.

KW - adenosine diphosphate

KW - breast carcinoma

KW - MCF-7 cultured tumor cells

KW - platelet aggregation

KW - platelet glycoproteins

UR - http://www.scopus.com/inward/record.url?scp=0029008105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029008105&partnerID=8YFLogxK

U2 - 10.1016/0049-3848(95)00113-6

DO - 10.1016/0049-3848(95)00113-6

M3 - Article

VL - 79

SP - 261

EP - 274

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 3

ER -